nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—RYR3—diaphragm—chronic obstructive pulmonary disease	0.157	0.821	CbGeAlD
Dantrolene—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.112	0.282	CbGbCtD
Dantrolene—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0754	0.19	CbGbCtD
Dantrolene—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0719	0.182	CbGbCtD
Dantrolene—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0641	0.162	CbGbCtD
Dantrolene—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0376	0.0949	CbGbCtD
Dantrolene—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0355	0.0897	CbGbCtD
Dantrolene—RYR3—Stimuli-sensing channels—TRPV4—chronic obstructive pulmonary disease	0.0172	0.128	CbGpPWpGaD
Dantrolene—RYR3—smooth muscle tissue—chronic obstructive pulmonary disease	0.0144	0.0755	CbGeAlD
Dantrolene—RYR1—Stimuli-sensing channels—TRPV4—chronic obstructive pulmonary disease	0.0127	0.0943	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.0126	0.0937	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.0112	0.0835	CbGpPWpGaD
Dantrolene—RYR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.0104	0.0541	CbGeAlD
Dantrolene—RYR3—lung—chronic obstructive pulmonary disease	0.00953	0.0498	CbGeAlD
Dantrolene—RYR1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00926	0.0691	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00826	0.0615	CbGpPWpGaD
Dantrolene—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00515	0.0384	CbGpPWpGaD
Dantrolene—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00455	0.0339	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00437	0.0326	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.0039	0.0291	CbGpPWpGaD
Dantrolene—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00372	0.0278	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00322	0.024	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00287	0.0214	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.00278	0.0207	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.00214	0.016	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.00205	0.0153	CbGpPWpGaD
Dantrolene—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00189	0.0141	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.00155	0.0116	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—NOS3—chronic obstructive pulmonary disease	0.00147	0.0109	CbGpPWpGaD
Dantrolene—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00145	0.0108	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.00137	0.0102	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IL1B—chronic obstructive pulmonary disease	0.00125	0.0093	CbGpPWpGaD
Dantrolene—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00112	0.00837	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—NOS3—chronic obstructive pulmonary disease	0.00108	0.00806	CbGpPWpGaD
Dantrolene—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00369	CcSEcCtD
Dantrolene—Pulmonary oedema—Prednisolone—chronic obstructive pulmonary disease	0.00102	0.00368	CcSEcCtD
Dantrolene—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00367	CcSEcCtD
Dantrolene—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00364	CcSEcCtD
Dantrolene—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00362	CcSEcCtD
Dantrolene—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000994	0.00358	CcSEcCtD
Dantrolene—Acne—Prednisone—chronic obstructive pulmonary disease	0.000992	0.00357	CcSEcCtD
Dantrolene—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000992	0.00357	CcSEcCtD
Dantrolene—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000986	0.00355	CcSEcCtD
Dantrolene—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000978	0.00352	CcSEcCtD
Dantrolene—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000976	0.00727	CbGpPWpGaD
Dantrolene—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000971	0.00349	CcSEcCtD
Dantrolene—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.000963	0.00346	CcSEcCtD
Dantrolene—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000957	0.00344	CcSEcCtD
Dantrolene—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000948	0.00341	CcSEcCtD
Dantrolene—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000948	0.00341	CcSEcCtD
Dantrolene—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00094	0.00338	CcSEcCtD
Dantrolene—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000939	0.00338	CcSEcCtD
Dantrolene—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000934	0.00336	CcSEcCtD
Dantrolene—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000934	0.00336	CcSEcCtD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL1B—chronic obstructive pulmonary disease	0.00092	0.00686	CbGpPWpGaD
Dantrolene—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000915	0.00329	CcSEcCtD
Dantrolene—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00091	0.00327	CcSEcCtD
Dantrolene—Tension—Formoterol—chronic obstructive pulmonary disease	0.00091	0.00327	CcSEcCtD
Dantrolene—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000908	0.00327	CcSEcCtD
Dantrolene—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000908	0.00327	CcSEcCtD
Dantrolene—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000903	0.00325	CcSEcCtD
Dantrolene—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000901	0.00324	CcSEcCtD
Dantrolene—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000901	0.00324	CcSEcCtD
Dantrolene—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000899	0.00323	CcSEcCtD
Dantrolene—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000897	0.00323	CcSEcCtD
Dantrolene—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000897	0.00323	CcSEcCtD
Dantrolene—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000888	0.00662	CbGpPWpGaD
Dantrolene—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000886	0.00319	CcSEcCtD
Dantrolene—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00088	0.00316	CcSEcCtD
Dantrolene—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000875	0.00315	CcSEcCtD
Dantrolene—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000864	0.00311	CcSEcCtD
Dantrolene—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00086	0.00309	CcSEcCtD
Dantrolene—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00086	0.00309	CcSEcCtD
Dantrolene—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000859	0.00309	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000858	0.0064	CbGpPWpGaD
Dantrolene—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000857	0.00308	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000854	0.00307	CcSEcCtD
Dantrolene—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00085	0.00306	CcSEcCtD
Dantrolene—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.00085	0.00634	CbGpPWpGaD
Dantrolene—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000848	0.00305	CcSEcCtD
Dantrolene—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000847	0.00305	CcSEcCtD
Dantrolene—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000836	0.00301	CcSEcCtD
Dantrolene—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000836	0.00301	CcSEcCtD
Dantrolene—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000826	0.00297	CcSEcCtD
Dantrolene—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000816	0.00608	CbGpPWpGaD
Dantrolene—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000813	0.00292	CcSEcCtD
Dantrolene—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000812	0.00292	CcSEcCtD
Dantrolene—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000802	0.00288	CcSEcCtD
Dantrolene—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000801	0.00288	CcSEcCtD
Dantrolene—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000801	0.00288	CcSEcCtD
Dantrolene—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00079	0.00284	CcSEcCtD
Dantrolene—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00079	0.00284	CcSEcCtD
Dantrolene—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000789	0.00284	CcSEcCtD
Dantrolene—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000789	0.00284	CcSEcCtD
Dantrolene—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000787	0.00283	CcSEcCtD
Dantrolene—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000786	0.00283	CcSEcCtD
Dantrolene—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000786	0.00283	CcSEcCtD
Dantrolene—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000785	0.00585	CbGpPWpGaD
Dantrolene—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00078	0.00281	CcSEcCtD
Dantrolene—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00078	0.00281	CcSEcCtD
Dantrolene—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000773	0.00278	CcSEcCtD
Dantrolene—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000772	0.00278	CcSEcCtD
Dantrolene—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000772	0.00278	CcSEcCtD
Dantrolene—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000767	0.00276	CcSEcCtD
Dantrolene—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000757	0.00272	CcSEcCtD
Dantrolene—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000757	0.00272	CcSEcCtD
Dantrolene—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000756	0.00272	CcSEcCtD
Dantrolene—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000745	0.00268	CcSEcCtD
Dantrolene—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000745	0.00268	CcSEcCtD
Dantrolene—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000743	0.00267	CcSEcCtD
Dantrolene—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000741	0.00267	CcSEcCtD
Dantrolene—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000741	0.00267	CcSEcCtD
Dantrolene—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000739	0.00266	CcSEcCtD
Dantrolene—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000739	0.00266	CcSEcCtD
Dantrolene—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000737	0.00265	CcSEcCtD
Dantrolene—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000736	0.00265	CcSEcCtD
Dantrolene—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000733	0.00263	CcSEcCtD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IL6—chronic obstructive pulmonary disease	0.000731	0.00545	CbGpPWpGaD
Dantrolene—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000729	0.00262	CcSEcCtD
Dantrolene—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000726	0.00261	CcSEcCtD
Dantrolene—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000715	0.00257	CcSEcCtD
Dantrolene—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000709	0.00528	CbGpPWpGaD
Dantrolene—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000704	0.00253	CcSEcCtD
Dantrolene—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.0007	0.00252	CcSEcCtD
Dantrolene—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000697	0.00251	CcSEcCtD
Dantrolene—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000691	0.00248	CcSEcCtD
Dantrolene—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000691	0.00248	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00069	0.00248	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00069	0.00248	CcSEcCtD
Dantrolene—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000685	0.00246	CcSEcCtD
Dantrolene—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000685	0.00246	CcSEcCtD
Dantrolene—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000681	0.00245	CcSEcCtD
Dantrolene—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00068	0.00507	CbGpPWpGaD
Dantrolene—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00068	0.00245	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000675	0.00243	CcSEcCtD
Dantrolene—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000673	0.00242	CcSEcCtD
Dantrolene—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000673	0.00242	CcSEcCtD
Dantrolene—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00067	0.00241	CcSEcCtD
Dantrolene—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000666	0.0024	CcSEcCtD
Dantrolene—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000666	0.0024	CcSEcCtD
Dantrolene—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000663	0.00239	CcSEcCtD
Dantrolene—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000659	0.00237	CcSEcCtD
Dantrolene—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000658	0.00236	CcSEcCtD
Dantrolene—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000653	0.00235	CcSEcCtD
Dantrolene—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000653	0.00235	CcSEcCtD
Dantrolene—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000653	0.00235	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000651	0.00234	CcSEcCtD
Dantrolene—Pain—Formoterol—chronic obstructive pulmonary disease	0.000647	0.00233	CcSEcCtD
Dantrolene—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000647	0.00233	CcSEcCtD
Dantrolene—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000647	0.00233	CcSEcCtD
Dantrolene—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000647	0.00233	CcSEcCtD
Dantrolene—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000646	0.00232	CcSEcCtD
Dantrolene—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000645	0.00481	CbGpPWpGaD
Dantrolene—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000639	0.0023	CcSEcCtD
Dantrolene—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000635	0.00228	CcSEcCtD
Dantrolene—Pain—Montelukast—chronic obstructive pulmonary disease	0.000634	0.00228	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000632	0.00471	CbGpPWpGaD
Dantrolene—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000632	0.00227	CcSEcCtD
Dantrolene—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000629	0.00226	CcSEcCtD
Dantrolene—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000627	0.00225	CcSEcCtD
Dantrolene—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000626	0.00225	CcSEcCtD
Dantrolene—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000624	0.00224	CcSEcCtD
Dantrolene—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000624	0.00224	CcSEcCtD
Dantrolene—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000623	0.00224	CcSEcCtD
Dantrolene—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000621	0.00223	CcSEcCtD
Dantrolene—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000621	0.00223	CcSEcCtD
Dantrolene—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00062	0.00223	CcSEcCtD
Dantrolene—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000619	0.00223	CcSEcCtD
Dantrolene—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000619	0.00223	CcSEcCtD
Dantrolene—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000616	0.00222	CcSEcCtD
Dantrolene—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000611	0.0022	CcSEcCtD
Dantrolene—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000611	0.0022	CcSEcCtD
Dantrolene—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000606	0.00218	CcSEcCtD
Dantrolene—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000606	0.00218	CcSEcCtD
Dantrolene—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000601	0.00216	CcSEcCtD
Dantrolene—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000601	0.00216	CcSEcCtD
Dantrolene—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000598	0.00215	CcSEcCtD
Dantrolene—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000598	0.00215	CcSEcCtD
Dantrolene—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000598	0.00215	CcSEcCtD
Dantrolene—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000598	0.00215	CcSEcCtD
Dantrolene—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000596	0.00214	CcSEcCtD
Dantrolene—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000593	0.00442	CbGpPWpGaD
Dantrolene—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000591	0.00213	CcSEcCtD
Dantrolene—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000591	0.00212	CcSEcCtD
Dantrolene—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000591	0.00212	CcSEcCtD
Dantrolene—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000589	0.00212	CcSEcCtD
Dantrolene—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000589	0.00212	CcSEcCtD
Dantrolene—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000587	0.00211	CcSEcCtD
Dantrolene—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000586	0.00211	CcSEcCtD
Dantrolene—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000586	0.00211	CcSEcCtD
Dantrolene—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000584	0.0021	CcSEcCtD
Dantrolene—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00058	0.00209	CcSEcCtD
Dantrolene—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000577	0.00207	CcSEcCtD
Dantrolene—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00057	0.00425	CbGpPWpGaD
Dantrolene—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000568	0.00204	CcSEcCtD
Dantrolene—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000565	0.00203	CcSEcCtD
Dantrolene—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000565	0.00203	CcSEcCtD
Dantrolene—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000558	0.00201	CcSEcCtD
Dantrolene—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000558	0.00201	CcSEcCtD
Dantrolene—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000557	0.002	CcSEcCtD
Dantrolene—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000556	0.002	CcSEcCtD
Dantrolene—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000546	0.00196	CcSEcCtD
Dantrolene—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000543	0.00195	CcSEcCtD
Dantrolene—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000543	0.00195	CcSEcCtD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL6—chronic obstructive pulmonary disease	0.000539	0.00402	CbGpPWpGaD
Dantrolene—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000535	0.00193	CcSEcCtD
Dantrolene—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000535	0.00193	CcSEcCtD
Dantrolene—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000534	0.00192	CcSEcCtD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000534	0.00398	CbGpPWpGaD
Dantrolene—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000532	0.00191	CcSEcCtD
Dantrolene—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000527	0.00189	CcSEcCtD
Dantrolene—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000524	0.00189	CcSEcCtD
Dantrolene—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000518	0.00186	CcSEcCtD
Dantrolene—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000518	0.00186	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000515	0.00384	CbGpPWpGaD
Dantrolene—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000513	0.00184	CcSEcCtD
Dantrolene—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000507	0.00182	CcSEcCtD
Dantrolene—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000506	0.00182	CcSEcCtD
Dantrolene—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000502	0.00181	CcSEcCtD
Dantrolene—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.0005	0.0018	CcSEcCtD
Dantrolene—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.0005	0.0018	CcSEcCtD
Dantrolene—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00049	0.00176	CcSEcCtD
Dantrolene—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000489	0.00176	CcSEcCtD
Dantrolene—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000481	0.00173	CcSEcCtD
Dantrolene—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000481	0.00173	CcSEcCtD
Dantrolene—Rash—Formoterol—chronic obstructive pulmonary disease	0.000477	0.00172	CcSEcCtD
Dantrolene—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000477	0.00172	CcSEcCtD
Dantrolene—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000477	0.00171	CcSEcCtD
Dantrolene—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000477	0.00171	CcSEcCtD
Dantrolene—Headache—Formoterol—chronic obstructive pulmonary disease	0.000474	0.00171	CcSEcCtD
Dantrolene—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000474	0.00171	CcSEcCtD
Dantrolene—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000473	0.0017	CcSEcCtD
Dantrolene—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000473	0.0017	CcSEcCtD
Dantrolene—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000471	0.0017	CcSEcCtD
Dantrolene—Rash—Montelukast—chronic obstructive pulmonary disease	0.000467	0.00168	CcSEcCtD
Dantrolene—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000467	0.00168	CcSEcCtD
Dantrolene—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000466	0.00168	CcSEcCtD
Dantrolene—Depression—Prednisone—chronic obstructive pulmonary disease	0.000466	0.00167	CcSEcCtD
Dantrolene—Headache—Montelukast—chronic obstructive pulmonary disease	0.000464	0.00167	CcSEcCtD
Dantrolene—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000454	0.00163	CcSEcCtD
Dantrolene—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000453	0.00163	CcSEcCtD
Dantrolene—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.00162	CcSEcCtD
Dantrolene—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00162	CcSEcCtD
Dantrolene—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00045	0.00162	CcSEcCtD
Dantrolene—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00045	0.00162	CcSEcCtD
Dantrolene—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00161	CcSEcCtD
Dantrolene—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00044	0.00158	CcSEcCtD
Dantrolene—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000435	0.00156	CcSEcCtD
Dantrolene—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000434	0.00156	CcSEcCtD
Dantrolene—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000424	0.00153	CcSEcCtD
Dantrolene—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000422	0.00152	CcSEcCtD
Dantrolene—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000421	0.00152	CcSEcCtD
Dantrolene—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000419	0.00151	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000419	0.00312	CbGpPWpGaD
Dantrolene—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00041	0.00147	CcSEcCtD
Dantrolene—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.0004	0.00144	CcSEcCtD
Dantrolene—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000396	0.00142	CcSEcCtD
Dantrolene—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000389	0.0014	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.00038	0.00283	CbGpPWpGaD
Dantrolene—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000371	0.00133	CcSEcCtD
Dantrolene—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000365	0.00131	CcSEcCtD
Dantrolene—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000351	0.00126	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000347	0.00258	CbGpPWpGaD
Dantrolene—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000344	0.00124	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000339	0.00253	CbGpPWpGaD
Dantrolene—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000339	0.00122	CcSEcCtD
Dantrolene—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000338	0.00121	CcSEcCtD
Dantrolene—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000337	0.00121	CcSEcCtD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000334	0.00249	CbGpPWpGaD
Dantrolene—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000329	0.00118	CcSEcCtD
Dantrolene—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.00117	CcSEcCtD
Dantrolene—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000316	0.00114	CcSEcCtD
Dantrolene—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000315	0.00113	CcSEcCtD
Dantrolene—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000311	0.00112	CcSEcCtD
Dantrolene—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000307	0.0011	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000305	0.00227	CbGpPWpGaD
Dantrolene—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000302	0.00109	CcSEcCtD
Dantrolene—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000298	0.00107	CcSEcCtD
Dantrolene—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000291	0.00105	CcSEcCtD
Dantrolene—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000288	0.00104	CcSEcCtD
Dantrolene—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000284	0.00102	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000275	0.00205	CbGpPWpGaD
Dantrolene—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000271	0.000976	CcSEcCtD
Dantrolene—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000271	0.000975	CcSEcCtD
Dantrolene—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000269	0.000969	CcSEcCtD
Dantrolene—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000262	0.000943	CcSEcCtD
Dantrolene—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000259	0.000931	CcSEcCtD
Dantrolene—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.000929	CcSEcCtD
Dantrolene—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.000929	CcSEcCtD
Dantrolene—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000257	0.000923	CcSEcCtD
Dantrolene—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000257	0.000923	CcSEcCtD
Dantrolene—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000255	0.000916	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000246	0.00184	CbGpPWpGaD
Dantrolene—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000245	0.000883	CcSEcCtD
Dantrolene—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000244	0.000876	CcSEcCtD
Dantrolene—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000243	0.000876	CcSEcCtD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000243	0.00181	CbGpPWpGaD
Dantrolene—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000851	CcSEcCtD
Dantrolene—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000847	CcSEcCtD
Dantrolene—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000847	CcSEcCtD
Dantrolene—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000789	CcSEcCtD
Dantrolene—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000769	CcSEcCtD
Dantrolene—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000758	CcSEcCtD
Dantrolene—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000733	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.0002	0.00149	CbGpPWpGaD
Dantrolene—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000708	CcSEcCtD
Dantrolene—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000681	CcSEcCtD
Dantrolene—Rash—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000675	CcSEcCtD
Dantrolene—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000675	CcSEcCtD
Dantrolene—Headache—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000671	CcSEcCtD
Dantrolene—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000636	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000176	0.00131	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000174	0.00129	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000146	0.00109	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000144	0.00107	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000122	0.000907	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00012	0.000895	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000112	0.000834	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00011	0.000822	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000106	0.00079	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.00078	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	8.53e-05	0.000636	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.65e-05	0.000421	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	5.5e-05	0.00041	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.11e-05	0.000381	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3e-05	0.000224	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.97e-05	0.000221	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.71e-05	0.000202	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.5e-05	0.000186	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.08e-05	0.000155	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.05e-05	0.000153	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.91e-05	0.000143	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.81e-05	0.000135	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.23e-05	9.19e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.18e-05	8.79e-05	CbGpPWpGaD
